The liver plays a central role in the body’s metabolism and immune regulation. Yet, many cellular mechanisms involved in liver diseases remain only partially understood. Researchers from Charité, Si-M – The Simulated Human and the Cincinnati Children’s Hospital Medical Center have now gained crucial…
The Berlin Institute of Health at Charité (BIH) is strengthening its research faculty in February with the appointments of Dr. Leif Si-Hun Ludwig and Dr. Daniel Ortmann. Ludwig has been awarded a prestigious Heisenberg professorship in stem cell dynamics and mitochondrial genomics, a position funded…
A team led by former BIH professor Prof. Dr. Sarah Hedtrich focused on a form of fish scale disease known as autosomal recessive congenital ichthyosis (ARCI). This is a rare, hereditary skin disorder that disrupts the formation of the body's skin cornea. Those affected often have dry, reddened and…
The Berlin Institute of Health at Charité (BIH) is pleased to welcome Prof. Dr. Katy Börner as a new Visiting Fellow. The internationally renowned scientist has been working at the BIH since June 2025 for a period of three years as part of the “Visiting Fellow” program funded by the Charité…
A person's metabolism is as unique as their fingerprint, and so is their risk of developing certain diseases. A better understanding of the genetic influences on metabolism could open up new therapeutic options. Researchers at the Berlin Institute of Health at Charité (BIH) and Queen Mary University…
The Berlin Institute of Health at Charité (BIH) is coordinating the central European research project "EU-CiP" (European Cancer Information Portal). This project is funded with 12 million euros over four years by the European Union's Horizon Europe program. For the first time, it establishes a…
Digitalisation can fundamentally change healthcare: faster processes, better data availability and more time for patients. But despite the technical possibilities, there are obstacles that slow down progress. How can digitalisation be designed in such a way that it does not remain a technological…
The Berlin Institute of Health at Charité (BIH) and ProBioGen today announced a major collaboration to manufacture materials for gene and cell therapies. The partnership was unveiled at the groundbreaking ceremony for the Berlin Center for Gene and Cell Therapies (BC GCT), which features a 4,600 m²…
An international research team bringing together Prof. Kirsten Kübler from the Berlin Institute of Health at Charité (BIH), and colleagues from Broad Institute of MIT and Harvard, Mass General Brigham and Dana-Farber Cancer Institute has identified a previously unknown mechanism by which the breast…
